Cite
Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence.
MLA
Barco, Stefano, et al. “Severe Plasma Prekallikrein Deficiency: Clinical Characteristics, Novel KLKB1 Mutations, and Estimated Prevalence.” Journal of Thrombosis and Haemostasis : JTH, vol. 18, no. 7, July 2020, pp. 1598–617. EBSCOhost, https://doi.org/10.1111/jth.14805.
APA
Barco, S., Sollfrank, S., Trinchero, A., Adenaeuer, A., Abolghasemi, H., Conti, L., Häuser, F., Kremer Hovinga, J. A., Lackner, K. J., Loewecke, F., Miloni, E., Vazifeh Shiran, N., Tomao, L., Wuillemin, W. A., Zieger, B., Lämmle, B., & Rossmann, H. (2020). Severe plasma prekallikrein deficiency: Clinical characteristics, novel KLKB1 mutations, and estimated prevalence. Journal of Thrombosis and Haemostasis : JTH, 18(7), 1598–1617. https://doi.org/10.1111/jth.14805
Chicago
Barco, Stefano, Stefanie Sollfrank, Alice Trinchero, Anke Adenaeuer, Hassan Abolghasemi, Laura Conti, Friederike Häuser, et al. 2020. “Severe Plasma Prekallikrein Deficiency: Clinical Characteristics, Novel KLKB1 Mutations, and Estimated Prevalence.” Journal of Thrombosis and Haemostasis : JTH 18 (7): 1598–1617. doi:10.1111/jth.14805.